广济药业：关于收到化学原料药再注册批准通知书的公告

Core Viewpoint - Guangji Pharmaceutical announced that its subsidiary, Hubei Huisheng Pharmaceutical Co., Ltd., has received approval from the Hubei Provincial Drug Administration for the re-registration of its chemical raw material, Vitamin B6 [1] Group 1 - The approval is documented in the "Chemical Raw Material Re-registration Approval Notice" issued by the regulatory authority [1]